VAGISIL Anti-Itch Medicated Creme Maximum Strength
NDC 11509-4402, Benzocaine and Resorcinol, cream, from Combe Incorporated.
- Product NDC
- 11509-4402
- Status
- Listed
- Labeler
- Combe Incorporated
- Dosage form
- CREAM
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M017
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/11509-4402 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BENZOCAINE200 mg/g
- RESORCINOL30 mg/g
Pharmacologic classes
Allergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Standardized Chemical Allergen [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 11509-4402-1 | 11509440201 | 1 TUBE in 1 CARTON (11509-4402-1) / 28 g in 1 TUBE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 11509-4402 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/11509-4402 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 11509-4402. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.